A comparison of disease burden in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Michelsen, Brigitte ^a   Fiane, Ragnhild ^b   Diamantopoulos, Andreas P ^a,b   Soldal, Dag Magnar ^a   Hansen, Inger Johanne W ^a   Sokka, Tuulikki ^c   Kavanaugh, Arthur ^d   Haugeberg, Glenn ^a,e  

^a Department of Rheumatology Hospital of Southern Norway Trust   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF AGDER   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG;

ADOLESCENT; ARTHRALGIA; ARTICLE; AXIAL SPONDYLOARTHRITIS; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; CLINICAL DISEASE ACTIVITY INDEX; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY SCORE; DISEASE CLASSIFICATION; FATIGUE; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NORWAY; PATIENT ASSESSMENT; PSORIATIC ARTHRITIS; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; ROUTINE ASSESSMENT OF PATIENT INDEX DATA; SELF REPORT; SPONDYLARTHRITIS; ADULT; AGED; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; COMPARATIVE STUDY; COST OF ILLNESS; INCIDENCE; MIDDLE AGED; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; ARTHRALGIA; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; FATIGUE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SPONDYLARTHRITIS;

EID: 84929493047     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0123582     Document Type: Article

References (50)

1. Riise T, Jacobsen BK, Gran JT. Incidence and prevalence of rheumatoid arthritis in the county of Troms, northern Norway. J Rheumatol 2000; 27: 1386-1389. PMID: 10852258
2. Madland TM, Apalset EM, Johannessen AE, Rossebo B, Brun JG. Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway. J Rheumatol 2005; 32: 1918-1922. PMID: 16206347
3. Bakland G, Nossent HC, Gran JT. Incidence and prevalence of ankylosing spondylitis in Northern Norway. Arthritis Rheum 2005; 53: 850-855. PMID: 16342091
4. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet 2010; 376: 1094-1108. doi: 10.1016/ S0140-6736(10)60826-4 PMID: 20870100
5. Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005; 64 Suppl 2: ii14-17. PMID: 15708927
6. Mease PJ, Armstrong AW. Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis. Drugs 2014; 74: 423-441. doi: 10.1007/ s40265-014-0191-y PMID: 24566842
7. Braun J, Sieper J. Ankylosing spondylitis. Lancet 2007; 369: 1379-1390. PMID: 17448825
8. Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009; 68: 777-783. doi: 10.1136/ard.2009.108233 PMID: 19297344
9. Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Annals of the Rheumatic Diseases 2009; 68: ii1-ii44. doi: 10.1136/ard.2008.104018 PMID: 19433414
10. Haroon M, Fitzgerald O. Pathogenetic overview of psoriatic disease. J Rheumatol Suppl 2012; 89: 7-10. doi: 10.3899/jrheum.120232 PMID: 22751581
11. Baraliakos X, Braun J. Spondyloarthritides. Best Pract Res Clin Rheumatol 2011; 25: 825-842. doi: 10. 1016/j.berh.2011.11.006 PMID: 22265264
12. Nam JL, Ramiro S, Gaujoux-Viala C, Takase K, Leon-Garcia M, Emery P, et al. Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 2014; 73: 516-528. doi: 10.1136/annrheumdis-2013-204577 PMID: 24399231
13. Smolen JS, Braun J, Dougados M, Emery P, Fitzgerald O, Helliwell P, et al. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis 2014; 73: 6-16. doi: 10.1136/annrheumdis-2013-203419 PMID: 23749611
14. Schoels M, Knevel R, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas DT, et al. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search. Ann Rheum Dis 2010; 69: 638-643. doi: 10.1136/ard.2009.123976 PMID: 20237123
15. Ruiz-Esquide V, Sanmarti R. Tobacco and other environmental risk factors in rheumatoid arthritis. Reumatol Clin 2012; 8: 342-350. doi: 10.1016/j.reuma.2012.02.011 PMID: 22609003
16. Zink A, Thiele K, Huscher D, Listing J, Sieper J, Krause A, et al. Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 2006; 33: 86-90. PMID: 16395755
17. Schett G, Coates LC, Ash ZR, Finzel S, Conaghan PG. Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future. Arthritis Res Ther 2011; 13 Suppl 1: S4. doi: 10.1186/1478-6354-13-S1-S4 PMID: 21624183
18. Salaffi F, Carotti M, Gasparini S, Intorcia M, Grassi W. The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people. Health Qual Life Outcomes 2009; 7: 25. doi: 10.1186/1477-7525-7-25 PMID: 19296831
19. Kvamme MK, Kristiansen IS, Lie E, Kvien TK. Identification of cutpoints for acceptable health status and important improvement in patient-reported outcomes, in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2010; 37: 26-31. doi: 10.3899/jrheum.090449 PMID: 19955045
20. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324. PMID: 3358796
21. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54: 2665-2673. PMID: 16871531
22. Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983; 26: 1346-1353. PMID: 6639693
23. Pincus T, Yazici Y, Bergman M, Maclean R, Harrington T. A proposed continuous quality improvement approach to assessment and management of patients with rheumatoid arthritis without formal joint counts, based on quantitative routine assessment of patient index data (RAPID) scores on a multidimensional health assessment questionnaire (MDHAQ). Best Pract Res Clin Rheumatol 2007; 21: 789-804. PMID: 17678835
24. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994; 21: 2281-2285. PMID: 7699629
25. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994; 21: 2286-2291. PMID: 7699630
26. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-48. PMID: 7818570
27. Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, Machold K, et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 2005; 7: R796-806. PMID: 15987481
28. Husted JA, Gladman DD, Farewell VT, Cook RJ. Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum 2001; 45: 151-158. PMID: 11324779
29. Rahman P, Nguyen E, Cheung C, Schentag CT, Gladman DD. Comparison of radiological severity in psoriatic arthritis and rheumatoid arthritis. J Rheumatol 2001; 28: 1041-1044. PMID: 11361186
30. Lindqvist UR, Alenius GM, Husmark T, Theander E, Holmstrom G, Larsson PT, et al. The Swedish early psoriatic arthritis register-2-year followup: a comparison with early rheumatoid arthritis. J Rheumatol 2008; 35: 668-673. PMID: 18278834
31. Heiberg T, Kvien TK. Preferences for improved health examined in 1, 024 patients with rheumatoid arthritis: pain has highest priority. Arthritis Rheum 2002; 47: 391-397. PMID: 12209485
32. Studenic P, Radner H, Smolen JS, Aletaha D. Discrepancies between patients and physicians in their perceptions of rheumatoid arthritis disease activity. Arthritis Rheum 2012; 64: 2814-2823. doi: 10. 1002/art.34543 PMID: 22810704
33. Kirwan JR, Hewlett SE, Heiberg T, Hughes RA, Carr M, Hehir M, et al. Incorporating the patient perspective into outcome assessment in rheumatoid arthritis-progress at OMERACT 7. J Rheumatol 2005; 32: 2250-2256. PMID: 16265712
34. Barnabe C, Bessette L, Flanagan C, Leclercq S, Steiman A, Kalache F, et al. Sex differences in pain scores and localization in inflammatory arthritis: a systematic review and metaanalysis. J Rheumatol 2012; 39: 1221-1230. doi: 10.3899/jrheum.111393 PMID: 22505697
35. www.nav.no/systemsider/sok/solrDokumenterAlle/attachment-356494?ts=140c49cd438 (Homepage to the Norwegian work and welfare management agency)
36. Louie GH, Reveille JD, Ward MM. Challenges comparing functional limitations in rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol 2009; 27: S83-91. PMID: 19822052
37. Gross RL, Schwartzman-Morris JS, Krathen M, Reed G, Chang H, Saunders KC, et al. A comparison of malignancy incidence among psoriatic and rheumatoid arthritis patients in a large US cohort. Arthritis Rheumatol 2014.
38. Ogdie A, Haynes K, Troxel AB, Love TJ, Hennessy S, Choi H, et al. Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study. Ann Rheum Dis 2014; 73: 149-153. doi: 10.1136/annrheumdis-2012-202424 PMID: 23264338
39. Jamnitski A, Symmons D, Peters MJ, Sattar N, McInnes I, Nurmohamed MT. Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Ann Rheum Dis 2013; 72: 211-216. doi: 10. 1136/annrheumdis-2011-201194 PMID: 22532629
40. Labitigan M, Bahce-Altuntas A, Kremer JM, Reed G, Greenberg JD, Jordan N, et al. Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis. Arthritis Care Res (Hoboken) 2014; 66: 600-607. doi: 10.1002/acr.22185 PMID: 24115739
41. Reddy SM, Anandarajah AP, Fisher MC, Mease PJ, Greenberg JD, Kremer JM, et al. Comparative analysis of disease activity measures, use of biologic agents, body mass index, radiographic features, and bone density in psoriatic arthritis and rheumatoid arthritis patients followed in a large U.S. disease registry. J Rheumatol 2010; 37: 2566-2572. doi: 10.3899/jrheum.100483 PMID: 20843908
42. Bhole VM, Choi HK, Burns LC, Vera Kellet C, Lacaille DV, Gladman DD, et al. Differences in body mass index among individuals with PsA, psoriasis, RA and the general population. Rheumatology (Oxford) 2012; 51: 552-556. doi: 10.1093/rheumatology/ker349 PMID: 22120603
43. Fransen J, Antoni C, Mease PJ, Uter W, Kavanaugh A, Kalden JR, et al. Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors. Ann Rheum Dis 2006; 65: 1373-1378. PMID: 16644783
44. Kavanaugh A, McInnes IB, Mease PJ, Krueger GG, Gladman DD, van der Heijde D, et al. Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL study. Ann Rheum Dis 2013; 72: 1777-1785. doi: 10.1136/annrheumdis-2012-202035 PMID: 23161902
45. Danve A. Routine Assessment Of Patient Index Data 3 Scores Correlate Well With Bath Ankylosing Spondylitis Disease Activity Index In The Assessment Of Disease Activity and Monitoring Progression Of Ankylosing Spondylitis. Artritis Rheum, 2013. Volume 65, October 2013 Abstract supplement, S648.
46. Sokka T, Haugeberg G, Asikainen J, Widding Hansen IJ, Kokko A, Rannio T, et al. Similar clinical outcomes in rheumatoid arthritis with more versus less expensive treatment strategies. Observational data from two rheumatology clinics. Clin Exp Rheumatol 2013; 31: 409-414. PMID: 23415074
47. Chen J, Veras MM, Liu C, Lin J. Methotrexate for ankylosing spondylitis. Cochrane Database Syst Rev 2013; 2: Cd004524.
48. Gossec L, Smolen JS, Gaujoux-Viala C, Ash Z, Marzo-Ortega H, van der Heijde D, et al. European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis 2012; 71: 4-12. doi: 10.1136/annrheumdis-2011-200350 PMID: 21953336
49. van den Berg R, Baraliakos X, Braun J, van der Heijde D. First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis. Rheumatology (Oxford) 2012; 51: 1388-1396. doi: 10.1093/rheumatology/kes066 PMID: 22513148
50. Schett G, Elewaut D, McInnes IB, Dayer JM, Neurath MF How cytokine networks fuel inflammation: Toward a cytokine-based disease taxonomy. Nat Med 2013; 19: 822-824. doi: 10.1038/nm.3260 PMID: 23836224